Merck & Co. Inc. (NYSE:MRK)

The valuation ratios exhibit significant volatility, particularly regarding profitability multiples, characterized by an extreme spike during the 2023 fiscal year followed by a period of normalization and a recent upward trend in early 2026. While revenue and book value multiples remained relatively stable, the price-to-earnings and price-to-operating profit ratios suggest substantial fluctuations in the underlying earnings and operating income during the analyzed period.

Price to Earnings (P/E) and Price to Operating Profit (P/OP)

Both ratios demonstrate a synchronized pattern of extreme expansion in 2023. The P/E ratio escalated from 22.92 in March 2023 to a peak of 893.99 in December 2023, while the P/OP ratio peaked at 138.56 during the same window. This divergence suggests a temporary and severe contraction in net income and operating profits relative to the stock price. Following this peak, both ratios reverted to historical norms throughout 2024 and 2025, with P/E fluctuating between 11.00 and 20.98. A renewed upward trajectory is evident by March 2026, with the P/E rising to 31.27 and P/OP to 23.37.

Price to Sales (P/S)

The price-to-sales ratio remained the most stable of the valuation metrics, fluctuating within a range of 3.17 to 5.43. A gradual increase was observed from March 2022 (4.12) to a peak in December 2023 (5.43). This was followed by a steady decline reaching a low of 3.17 in June 2025, before recovering to 4.25 by March 2026. The relative stability of this ratio indicates that the stock price remained more closely aligned with revenue generation than with bottom-line profitability.

Price to Book Value (P/BV)

The P/BV ratio followed a cyclical trajectory. An upward trend occurred between March 2022 (5.44) and December 2023, where it reached a maximum of 8.68. A subsequent correction took place throughout 2024 and 2025, with the ratio descending to a trough of 4.04 in September 2025. By March 2026, the ratio recovered to 6.09, indicating a return to valuation levels similar to those seen in early 2022.

The valuation metrics for the period between March 2022 and March 2026 exhibit significant volatility, characterized by a dramatic divergence between share price and earnings per share (EPS) during 2023, followed by a period of stabilization and a subsequent shift in valuation multiples.

Share Price Dynamics

The share price demonstrated a general upward trajectory from March 2022 (88.01 US$) to a peak in December 2023 (128.84 US$). Following this peak, a sustained decline occurred, reaching a low of 80.79 US$ by June 2025. A sharp recovery is noted in the final quarter of 2025, peaking at 123.93 US$ in December 2025, before slightly retreating to 113.11 US$ in March 2026.

Earnings Per Share (EPS) Performance

EPS remained relatively stable between 5.61 US$ and 6.54 US$ throughout 2022. However, a severe contraction occurred in 2023, with earnings falling to 1.23 US$ in June and reaching a critical low of 0.14 US$ in December 2023. A recovery phase began in 2024, with EPS returning to levels above 5.00 US$ by June 2024 and reaching a peak of 7.67 US$ in September 2025. A significant decrease to 3.62 US$ is observed in the final period ending March 2026.

Price-to-Earnings (P/E) Ratio Interpretation

The P/E ratio experienced extreme fluctuations primarily driven by earnings volatility rather than price movements. Between March 2022 and December 2022, the ratio remained in a conventional range of 13.36 to 19.21. The collapse in EPS during 2023 resulted in an anomalous valuation spike, peaking at 893.99 in December 2023, as the share price remained high while earnings nearly vanished. Valuation normalized in June 2024 to 20.73 as earnings recovered. For much of 2024 and 2025, the P/E ratio remained compressed between 11.00 and 13.49, suggesting a period of undervaluation or market caution. The ratio increased again to 31.27 by March 2026, corresponding with the sharp decline in EPS from the previous quarter.

The analyzed period exhibits significant volatility in valuation metrics, characterized by a pronounced disconnect between market pricing and operational profitability during the 2023 fiscal year, followed by a period of stabilization and subsequent divergence in early 2026.

Share Price Movement

The share price demonstrated a general upward trajectory from March 2022 ($88.01) through December 2023, reaching a peak of $128.84. This was followed by a steady decline throughout 2024 and the first half of 2025, bottoming at $80.79 in June 2025. A sharp recovery occurred in late 2025, with the price climbing to $123.93 by December 2025, before settling at $113.11 in March 2026.

Operating Profit per Share Trends

Operational profitability remained relatively stable between $6.16 and $7.46 throughout 2022. However, a severe contraction occurred in 2023, with operating profit per share plummeting to a low of $0.93 by December 31, 2023. Profitability recovered strongly in 2024 and 2025, maintaining a range between $5.39 and $8.73 during this window. A renewed decline is noted in the final quarter of the sequence, falling to $4.84 by March 31, 2026.

Price to Operating Profit (P/OP) Ratio Analysis

The P/OP ratio remained within a moderate range of 11.72 to 18.53 from March 2022 to March 2023. A period of extreme valuation expansion followed, peaking at 138.56 in December 2023; this anomaly was driven by the collapse in operating profit while the share price remained elevated. Valuation ratios normalized rapidly in June 2024 (18.41) and entered a period of compression through September 2025, reaching a low of 9.67. This indicates a phase where the market price was low relative to the strengthened operational earnings. The period concludes with a sharp increase in the ratio to 23.37 in March 2026, resulting from a simultaneous decrease in operating profit and a relatively high share price.

The valuation of the company, as measured by the Price to Sales (P/S) ratio, exhibited significant volatility between March 2022 and March 2026, characterized by a period of expansion, a subsequent contraction, and a recent recovery. Throughout this entire timeframe, sales per share maintained a consistent and linear upward trajectory, growing from 21.35 US$ to 26.63 US$.

Revenue Growth Trends

Sales per share demonstrated steady growth across every quarter of the analyzed period. This consistent increase indicates a strong underlying growth in revenue generation relative to the number of shares outstanding, independent of the fluctuations in market valuation.

Valuation Expansion and Peak

The P/S ratio experienced an initial upward trend, starting at 4.12 in March 2022 and reaching a peak of 5.43 by December 2023. This peak was primarily driven by a substantial increase in the share price, which reached 128.84 US$ during that quarter.

Valuation Contraction Period

A period of valuation compression occurred between March 2024 and June 2025. During this interval, the P/S ratio declined from 5.26 to a low of 3.17. This downward movement persisted despite the continued rise in sales per share, indicating that the market's willingness to pay a premium for each dollar of sales decreased significantly as the share price fell to 80.79 US$.

Recent Recovery and Stabilization

A sharp rebound in the P/S ratio was observed in late 2025, with the ratio climbing to 4.71 in December 2025. This was a direct result of the share price recovering to 123.93 US$. By March 2026, the ratio moderated to 4.25, bringing the valuation back toward levels observed in the earliest part of the analyzed period.

The valuation of the common stock exhibits significant volatility in the Price to Book Value (P/BV) ratio over the observed period from March 2022 to March 2026. The ratio reflects a fluctuating relationship between market sentiment, as expressed through the share price, and the underlying accounting value of the company.

P/BV Ratio Trend Analysis

The P/BV ratio experienced a steady ascent from 5.44 in March 2022, reaching an initial peak of 6.96 in June 2023. A sharp increase followed, culminating in a period high of 8.68 by December 2023. Subsequently, a prolonged contraction occurred, with the ratio declining consistently over several quarters to a period low of 4.04 in September 2025. A recovery phase is evident in the final two quarters, with the ratio climbing back to 6.09 by March 2026.

Book Value per Share (BVPS) Dynamics

The BVPS demonstrated a general upward trajectory, rising from 16.17 USD in March 2022 to a peak of 21.28 USD in December 2025. However, this growth was not linear, characterized by notable contractions in June 2023 (15.25 USD) and December 2023 (14.84 USD). A final decline to 18.58 USD was recorded in March 2026, suggesting a recent reduction in equity value per share.

Share Price Influence on Valuation

Market pricing acted as the primary driver of the P/BV fluctuations. The valuation peak in December 2023 was the result of a converging trend where the share price reached 128.84 USD while the BVPS simultaneously hit a local minimum of 14.84 USD. Conversely, the valuation trough in September 2025 was driven by a combination of a depressed share price (84.39 USD) and a steadily increasing book value (20.89 USD). The subsequent rebound in P/BV during late 2025 and early 2026 is attributed to a sharp recovery in the share price, which rose to 123.93 USD in December 2025.

Correlation Summary

The data indicates that the P/BV ratio is more sensitive to share price volatility than to changes in book value. While BVPS generally trended upward over the long term, the sharp spikes and drops in the P/BV ratio align closely with the cyclical movements of the market price, particularly during the period of contraction between 2024 and mid-2025.